89 related articles for article (PubMed ID: 1437304)
1. Ki67 immunohistochemical evaluation in colorectal cancer and normal colonic mucosa. Possible clinical applications.
Berenzi A; Benetti A; Bertalot G; Rodolfi A; Portolani N; Giulini SM; Pulcini G; Vinco A; Tiberio G
Pathologica; 1992; 84(1090):155-63. PubMed ID: 1437304
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas.
Sahin AA; Ro JY; Brown RW; Ordonez NG; Cleary KR; el-Naggar AK; Wilson P; Ayala AG
Mod Pathol; 1994 Jan; 7(1):17-22. PubMed ID: 8159647
[TBL] [Abstract][Full Text] [Related]
3. [The malignancy potential of colorectal polyps--histomorphometric, histochemical and immunohistochemical study of the dysplasia-carcinoma sequence].
Dippe B; Petrowsky H; Krüger S; von Jentzkowski K; Schneider M; Lorenz M
Zentralbl Chir; 1995; 120(7):556-63. PubMed ID: 7676754
[TBL] [Abstract][Full Text] [Related]
4. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
[TBL] [Abstract][Full Text] [Related]
5. Validation of the galactose oxidase-Schiff's reagent sequence for early detection and prognosis in human colorectal adenocarcinoma.
Carter JH; Deddens JA; Pullman JL; Colligan BM; Whiteley LO; Carter HW
Clin Cancer Res; 1997 Sep; 3(9):1479-89. PubMed ID: 9815834
[TBL] [Abstract][Full Text] [Related]
6. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
7. Two-dimensional electrophoretic study of normal colon mucosa and colorectal cancer.
Kovarova H; Stulík J; Hochstrasser DF; Bures J; Melichar B; Jandík P
Appl Theor Electrophor; 1994; 4(3):103-6. PubMed ID: 7612691
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in proliferation markers in colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Pahlman L; Glimelius B
Anticancer Res; 1995; 15(6B):2755-61. PubMed ID: 8669859
[TBL] [Abstract][Full Text] [Related]
10. HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant.
Benevolo M; Mottolese M; Piperno G; Sperduti I; Cione A; Sibilio L; Martayan A; Donnorso RP; Cosimelli M; Giacomini P
Am J Surg Pathol; 2007 Jan; 31(1):76-84. PubMed ID: 17197922
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
Komatsu K; Andoh A; Ishiguro S; Suzuki N; Hunai H; Kobune-Fujiwara Y; Kameyama M; Miyoshi J; Akedo H; Nakamura H
Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.
Akedo I; Ishikawa H; Ioka T; Kaji I; Narahara H; Ishiguro S; Suzuki T; Otani T
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):925-30. PubMed ID: 11535542
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
14. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
[TBL] [Abstract][Full Text] [Related]
15. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations.
Shepherd NA; Richman PI; England J
J Pathol; 1988 Jul; 155(3):213-9. PubMed ID: 3411382
[TBL] [Abstract][Full Text] [Related]
17. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in colorectal adenomas containing invasive carcinoma.
Risio M; Rossini FP
Anticancer Res; 1993; 13(1):43-7. PubMed ID: 8097391
[TBL] [Abstract][Full Text] [Related]
19. [P53 protein in adenocarcinoma of the large intestine].
Paluszkiewicz P; Pawłowska-Wakowicz B; Cybulski M; Berbeć H
Wiad Lek; 1997; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
[TBL] [Abstract][Full Text] [Related]
20. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
Feng H; Song JD
Ai Zheng; 2002 Jun; 21(6):658-62. PubMed ID: 12452070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]